0
Mortality in Offspring of Parents With Psychotic Disorders: A Critical Review and Meta-Analysis
Roger Webb, M.Sc.; Kathryn Abel, Ph.D., M.R.C.Psych.; Andrew Pickles, Ph.D.; Louis Appleby, M.D., F.R.C.Psych.
Abnormal Brain Activation During Inhibition and Error Detection in Medication-Naive Adolescents With ADHD
Katya Rubia, Ph.D.; Anna B. Smith, Ph.D.; Michael J. Brammer, Ph.D.; Brian Toone, Ph.D.; Eric Taylor, M.D., Ph.D.
Inhibition of Motor Responses in Siblings Concordant and Discordant for Attention Deficit Hyperactivity Disorder
Russell J. Schachar, M.D.; Jennifer Crosbie, Ph.D.; Cathy L. Barr, Ph.D.; Tisha J. Ornstein, Ph.D.; James Kennedy, M.D.; Molly Malone, Ph.D.; Wendy Roberts, M.D.; Abel Ickowicz, M.D.; Rosemary Tannock, Ph.D.; Shirley Chen, M.D., M.P.H.; Tejaswee Pathare, M.A.
Absence of Gender Effects on Attention Deficit Hyperactivity Disorder: Findings in Nonreferred Subjects
Joseph Biederman, M.D.; Anne Kwon, M.S.; Megan Aleardi, B.A.; Virginie-Anne Chouinard, B.Sc.; Teresa Marino, B.A.; Heather Cole, B.A.; Eric Mick, Sc.D.; Stephen V. Faraone, Ph.D.
Lower Prepulse Inhibition in Children With the 22q11 Deletion Syndrome
Christina Sobin, Ph.D.; Karen Kiley-Brabeck, Ph.D.; Maria Karayiorgou, M.D.
Response to Emotional Stimuli in Boys With Conduct Disorder
Sabine C. Herpertz, M.D.; Bodo Mueller, M.D.; Mutaz Qunaibi, B.Sc.; Christiane Lichterfeld, M.D.; Kerstin Konrad, Ph.D.; Beate Herpertz-Dahlmann, M.D.
Validity of DSM-IV Conduct Disorder in 4½–5-Year-Old Children: A Longitudinal Epidemiological Study
Julia Kim-Cohen, Ph.D.; Louise Arseneault, Ph.D.; Avshalom Caspi, Ph.D.; Mónica Polo Tomás, B.Sc.; Alan Taylor, M.A., M.Sc.; Terrie E. Moffitt, Ph.D.
Adaptive, Emotional, and Family Functioning of Children With Obsessive-Compulsive Disorder and Comorbid Attention Deficit Hyperactivity Disorder
Denis G. Sukhodolsky, Ph.D.; Maria C. do Rosario-Campos, M.D.; Lawrence Scahill, M.S.N., Ph.D.; Lily Katsovich, M.S.; David L. Pauls, Ph.D.; Bradley S. Peterson, M.D.; Robert A. King, M.D.; Paul J. Lombroso, M.D.; Diane B. Findley, Ph.D.; James F. Leckman, M.D.
Pervasive Developmental Disorders in Preschool Children: Confirmation of High Prevalence
Suniti Chakrabarti, M.D., F.R.C.P.C.H., M.R.C.P.; Eric Fombonne, M.D., F.R.C.Psych.
Risperidone for the Core Symptom Domains of Autism: Results From the Study by the Autism Network of the Research Units on Pediatric Psychopharmacology
Christopher J. McDougle, M.D.; Lawrence Scahill, M.S.N., Ph.D.; Michael G. Aman, Ph.D.; James T. McCracken, M.D.; Elaine Tierney, M.D.; Mark Davies, M.P.H.; L. Eugene Arnold, M.D.; David J. Posey, M.D.; Andrès Martin, M.D., M.P.H.; Jaswinder K. Ghuman, M.D.; Bhavik Shah, M.D.; Shirley Z. Chuang, M.S.; Naomi B. Swiezy, Ph.D.; Nilda M. Gonzalez, M.D.; Jill Hollway, B.A.; Kathleen Koenig, M.S.N.; James J. McGough, M.D.; Louise Ritz, M.B.A.; Benedetto Vitiello, M.D.
Quality Improvement for Depression in Primary Care: Do Patients With Subthreshold Depression Benefit in the Long Run?
Kenneth Wells, M.D., M.P.H.; Cathy Sherbourne, Ph.D.; Naihua Duan, Ph.D.; Jürgen Unützer, M.D., M.P.H; Jeanne Miranda, Ph.D.; Michael Schoenbaum, Ph.D.; Susan L. Ettner, Ph.D.; Lisa S. Meredith, Ph.D.; Lisa Rubenstein, M.D., M.S.H.S.
Computer-Assisted Cognitive Therapy for Depression: Maintaining Efficacy While Reducing Therapist Time
Jesse H. Wright, M.D., Ph.D.; Andrew S. Wright, M.D.; Anne Marie Albano, Ph.D.; Monica R. Basco, Ph.D.; L. Jane Goldsmith, Ph.D.; Troy Raffield, M.A.; Michael W. Otto, Ph.D.
Relationship Between Release of Platelet/Endothelial Biomarkers and Plasma Levels of Sertraline and N-Desmethylsertraline in Acute Coronary Syndrome Patients Receiving SSRI Treatment for Depression
Victor L. Serebruany, M.D., Ph.D.; Raymond F. Suckow, Ph.D.; Thomas B. Cooper, M.D.; Christopher M. O’Connor, M.D.; Alex I. Malinin, M.D.; K. Ranga R. Krishnan, M.D.; Louis T. van Zyl, M.D., M.Med.; Vladimir Lekht, M.D.; Alexander H. Glassman, M.D.; Sertraline Antidepressant Heart Attack Randomized Trial
Quality-of-Life Impairment in Depressive and Anxiety Disorders
Mark Hyman Rapaport, M.D.; Cathryn Clary, M.D.; Rana Fayyad, Ph.D.; Jean Endicott, Ph.D.
Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study
Steven E. Bruce, Ph.D.; Kimberly A. Yonkers, M.D.; Michael W. Otto, Ph.D.; Jane L. Eisen, M.D.; Risa B. Weisberg, Ph.D.; Maria Pagano, Ph.D.; M. Tracie Shea, Ph.D.; Martin B. Keller, M.D.
PTSD Following Terrorist Attacks: A Prospective Evaluation
Arieh Y. Shalev, M.D.; Sara Freedman, M.Sc.
Enhanced Cortisol Suppression Following Dexamethasone Administration in Domestic Violence Survivors
Michael G. Griffin, Ph.D.; Patricia A. Resick, Ph.D.; Rachel Yehuda, Ph.D.
Lamina-Specific Reductions in Dendritic Spine Density in the Prefrontal Cortex of Subjects With Schizophrenia
Nutan Kolluri, Ph.D.; Zhuoxin Sun, Ph.D.; Allan R. Sampson, Ph.D.; David A. Lewis, M.D.
Reduced Cerebellar Inhibition in Schizophrenia: A Preliminary Study
Zafiris J. Daskalakis, M.D., Ph.D., F.R.C.P.(C); Bruce K. Christensen, Ph.D., C.Psych.; Paul B. Fitzgerald, M.B.B.S., M.P.M., Ph.D., F.R.A.N.Z.C.P.; Sarah I. Fountain, B.Sc.; Robert Chen, M.B.B.Chir., M.Sc., F.R.C.P.(C)
Executive Function and Cognitive Subprocesses in First-Episode, Drug-Naive Schizophrenia: An Analysis of N-Back Performance
Stephan Krieger, Ph.D.; Stefanie Lis, Ph.D.; Turan Cetin, M.D.; Bernd Gallhofer, M.D.; Andreas Meyer-Lindenberg, M.D., Ph.D.
Informed Consent in Medication-Free Schizophrenia Research
David J. Moser, Ph.D.; Rebecca L. Reese, B.S.; Susan K. Schultz, M.D.; Michelle L. Benjamin, B.S.; Stephan Arndt, Ph.D.; Frank W. Fleming, B.S.N.; Nancy C. Andreasen, M.D., Ph.D.
Increased Amygdala Activation During Mania: A Functional Magnetic Resonance Imaging Study
Lori Altshuler, M.D.; Susan Bookheimer, Ph.D.; Manuel A. Proenza, B.S.; Jennifer Townsend, B.A.; Fred Sabb, B.S.; Ann Firestine, B.A.; George Bartzokis, M.D.; Jim Mintz, Ph.D.; John Mazziotta, M.D., Ph.D.; Mark S. Cohen, Ph.D.
Cost-Effective Screening for the Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotic Medications
David Straker, D.O.; Christoph U. Correll, M.D.; Elisse Kramer-Ginsberg, Ph.D.; Nasreen Abdulhamid, D.O.; Fiju Koshy, D.O.; Elayna Rubens, M.D.; Robert Saint-Vil, D.O.; John M. Kane, M.D.; Peter Manu, M.D.
Double-Blind, Placebo-Controlled Study of Dialectical Behavior Therapy Plus Olanzapine for Borderline Personality Disorder
Joaquim Soler, Psy.D.; Juan Carlos Pascual, M.D.; Josefa Campins, Psy.D.; Judith Barrachina, Psy.D.; Dolors Puigdemont, M.D.; Enrique Alvarez, M.D., Ph.D.; Victor Pérez, M.D., Ph.D.
Positional Asphyxiation From Paroxetine
ASIF MALIK, M.D.; SAJID RAVASIA, M.D.
Toxicity With Selective Serotonin Reuptake Inhibitors
KEVIN SOLOMONS, M.D.; SAMANTHA GOOCH, B.Sc.; ALLAN WONG, M.D.
Conn’s Syndrome Presenting as Depression
KHURSHID A. KHURSHID, M.D.; MARK E. WEAVER, M.D.
Defining “Health Correlates” in Recreational Gambling
CINDY SULLIVAN KERBER, Ph.D., A.P.N., C.S.
Dr. Desai and Colleagues Reply
RANI A. DESAI, Ph.D., M.P.H.; PAUL K. MACIEJEWSKI, Ph.D.; DAVID J. DAUSEY, Ph.D.; BARBARA J. CALDARONE, Ph.D.; MARC N. POTENZA, M.D., Ph.D.
Infanticide
NEIL S. KAYE, M.D.
Dr. Spinelli Replies
MARGARET G. SPINELLI, M.D.
Reduced Intracortical Myelination in Schizophrenia
GEORGE BARTZOKIS, M.D.; LORI ALTSHULER, M.D.
Hippocampus, VI: Depression and the Hippocampus
Alexander Neumeister, M.D.; Dennis S. Charney, M.D.; Wayne C. Drevets, M.D.
Melancholia
Gordon Parker, M.D., Ph.D., D.Sc., F.R.A.N.Z.C.P.
Grassroots Therapy
William Houghton, M.D.